Aphria (APHA) stock forecast for 2023
The forecast has been updated: June 13, 2021 11:48
Aphria stock price online today
Analyst Target Price
NoneDividend Date
-Ex Dividend Date
-Last Split Factor
0:1Last Split Date
03.05.2021Should you buy or sell Aphria stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Aphria stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $None target price for Aphria stock stock.
Today 200 Day Moving Average is the support level (15.2105 $).
50 Day Moving Average is the resistance level (17.5641 $).
APHA Forecast for 2023
Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
Jan | 16.59 | 15.01 | 17.40 | 13.73 % |
Feb | 15.87 | 14.50 | 16.99 | 14.63 % |
Mar | 13.99 | 12.38 | 15.45 | 19.88 % |
Apr | 13.74 | 11.93 | 14.33 | 16.74 % |
May | 14.85 | 13.00 | 15.81 | 17.75 % |
Jun | 15.60 | 14.19 | 17.23 | 17.60 % |
Jul | 17.62 | 16.86 | 18.86 | 10.60 % |
Aug | 18.70 | 17.52 | 20.58 | 14.88 % |
Sep | 17.35 | 15.63 | 18.38 | 14.95 % |
Oct | 14.60 | 13.00 | 16.57 | 21.57 % |
Nov | 15.13 | 13.96 | 17.25 | 19.10 % |
Dec | 15.97 | 14.48 | 18.07 | 19.89 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Aphria stock.
Aphria overview
Aphria Address
98 Talbot Street West, Leamington, ON, Canada, N8H 1M8Market Capitalization
6 861 894 656 $EBITDA
9 038 000PE Ratio
NonePEG Ratio
NoneDividend Per Share
NoneDividend Yield
0EPS
0.299Quarterly Earnings Growth YOY
-0.273Quarterly Revenue Growth YOY
0.064Trailing PE
0Forward PE
158.7302EV To Revenue
12.3289EV To EBITDA
454.678352 Week High
24.552 Week Low
3.9650 Day Moving Average
17.5641200 Day Moving Average
15.2105Shares Outstanding
316795008Shares Float
311226156Shares Short Prior Month
15981428Short Ratio
1.91Percent Insiders
0.111Percent Institutions
19.083Aphria stock forecast for this year
Aphria stock forecast for Jan 2023.
Estimated Average Forecasted Aphria Price: 16.59. Negative monthly dynamics of the instrument is expected with 13.733% volatility is expected.
Pessimistic forecast: 15.01
Optimistic: 17.40
Aphria stock forecast for Feb 2023.
Estimated Average Forecasted Aphria Price: 15.87. Negative monthly dynamics of the instrument is expected with 14.633% volatility is expected.
Pessimistic forecast: 14.50
Optimistic: 16.99
Aphria stock forecast for Mar 2023.
Estimated Average Forecasted Aphria Price: 13.99. Negative monthly dynamics of the instrument is expected with 19.884% volatility is expected.
Pessimistic forecast: 12.38
Optimistic: 15.45
Aphria stock forecast for Apr 2023.
Estimated Average Forecasted Aphria Price: 13.74. Negative monthly dynamics of the instrument is expected with 16.737% volatility is expected.
Pessimistic forecast: 11.93
Optimistic: 14.33
Aphria stock forecast for May 2023.
Estimated Average Forecasted Aphria Price: 14.85. Positive monthly dynamics of the instrument is expected with 17.750% volatility is expected.
Pessimistic forecast: 13.00
Optimistic: 15.81
Aphria stock forecast for Jun 2023.
Estimated Average Forecasted Aphria Price: 15.60. Positive monthly dynamics of the instrument is expected with 17.603% volatility is expected.
Pessimistic forecast: 14.19
Optimistic: 17.23
Aphria stock forecast for Jul 2023.
Estimated Average Forecasted Aphria Price: 17.62. Positive monthly dynamics of the instrument is expected with 10.596% volatility is expected.
Pessimistic forecast: 16.86
Optimistic: 18.86
Aphria stock forecast for Aug 2023.
Estimated Average Forecasted Aphria Price: 18.70. Positive monthly dynamics of the instrument is expected with 14.880% volatility is expected.
Pessimistic forecast: 17.52
Optimistic: 20.58
Aphria stock forecast for Sep 2023.
Estimated Average Forecasted Aphria Price: 17.35. Negative monthly dynamics of the instrument is expected with 14.952% volatility is expected.
Pessimistic forecast: 15.63
Optimistic: 18.38
Aphria stock forecast for Oct 2023.
Estimated Average Forecasted Aphria Price: 14.60. Negative monthly dynamics of the instrument is expected with 21.568% volatility is expected.
Pessimistic forecast: 13.00
Optimistic: 16.57
Aphria stock forecast for Nov 2023.
Estimated Average Forecasted Aphria Price: 15.13. Positive monthly dynamics of the instrument is expected with 19.098% volatility is expected.
Pessimistic forecast: 13.96
Optimistic: 17.25
Aphria stock forecast for Dec 2023.
Estimated Average Forecasted Aphria Price: 15.97. Positive monthly dynamics of the instrument is expected with 19.887% volatility is expected.
Pessimistic forecast: 14.48
Optimistic: 18.07
Other Healthcare sector assets
Name | Symbol | Last Close Price | Change |
---|---|---|---|
Abbott Laboratories
|
ABT | 110.48 (14.06.2021) | 0.52 % |
AbbVie Inc.
|
ABBV | 115.4 (14.06.2021) | -0.02 % |
Aeterna Zentaris Inc.
|
AEZS | 1.02 (14.06.2021) | -2.86 % |
Allakos Inc.
|
ALLK | 90.87 (14.06.2021) | -3.24 % |
Allogene Therapeutics, Inc.
|
ALLO | 25.37 (14.06.2021) | -2.80 % |
Amgen Inc.
|
AMGN | 241.19 (14.06.2021) | -0.65 % |
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
Atara Biotherapeutics, Inc.
|
ATRA | 14.66 (14.06.2021) | 1.81 % |
Aurora Cannabis Inc.
|
ACB | 9.67 (14.06.2021) | -1.53 % |
Becton Dickinson and Company
|
BDX | 242.72 (14.06.2021) | 0.03 % |
Biogen Inc.
|
BIIB | 406.14 (14.06.2021) | 2.40 % |
Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 100.4 (14.06.2021) | -4.40 % |
BioNTech SE
|
BNTX | 220.58 (14.06.2021) | -7.53 % |
bluebird bio, Inc.
|
BLUE | 33.53 (14.06.2021) | -1.67 % |
Boston Scientific Corp.
|
BSX | 42.54 (14.06.2021) | -0.86 % |
Bristol-Myers Squibb Company
|
BMY | 67.29 (14.06.2021) | -0.07 % |
Canopy Growth Corp.
|
CGC | 25.14 (14.06.2021) | -2.82 % |
Castle Biosciences, Inc.
|
CSTL | 71.86 (14.06.2021) | -0.04 % |
Eli Lilly and Company
|
LLY | 226.1 (14.06.2021) | 0.90 % |
Emergent BioSolutions Inc.
|
EBS | 61.79 (14.06.2021) | -2.71 % |
Exelixis, Inc.
|
EXEL | 22.76 (14.06.2021) | -0.96 % |
G1 Therapeutics, Inc.
|
GTHX | 22.75 (14.06.2021) | 5.23 % |
Gilead Sciences, Inc.
|
GILD | 68.15 (14.06.2021) | -0.90 % |
GlaxoSmithKline plc
|
GSK | 40.49 (14.06.2021) | 0.85 % |
GoodRx Holdings, Inc.
|
GDRX | 38.33 (14.06.2021) | 4.21 % |
GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
Incyte Corp.
|
INCY | 82.64 (14.06.2021) | 0.07 % |
Inovio Pharmaceuticals, Inc.
|
INO | 8.91 (14.06.2021) | -2.09 % |
Johnson & Johnson
|
JNJ | 165.37 (14.06.2021) | 0.25 % |
Medtronic plc.
|
MDT | 124.15 (14.06.2021) | 0.30 % |
Merck & Co., Inc.
|
MRK | 75.45 (14.06.2021) | -1.08 % |
Moderna, Inc.
|
MRNA | 207.41 (14.06.2021) | -5.23 % |
Novartis AG
|
NVS | 93.59 (14.06.2021) | 0.97 % |
Novavax, Inc.
|
NVAX | 207.71 (14.06.2021) | -0.94 % |
ObsEva SA
|
OBSV | 3.17 (14.06.2021) | -0.63 % |
OrganiGram Holdings Inc.
|
OGI | 3.14 (14.06.2021) | -1.26 % |
Pfizer Inc.
|
PFE | 39.63 (14.06.2021) | -1.30 % |
Regeneron Pharmaceuticals, Inc.
|
REGN | 528.75 (14.06.2021) | 0.61 % |
Sanofi
|
SNY | 54.25 (14.06.2021) | 0.84 % |
Schrodinger, Inc.
|
SDGR | 76.34 (14.06.2021) | -1.51 % |
Senseonics Holdings, Inc.
|
SENS | 3.96 (14.06.2021) | -1.25 % |
Sorrento Therapeutics, Inc.
|
SRNE | 9.46 (14.06.2021) | 6.65 % |
Stryker Corp.
|
SYK | 255.69 (14.06.2021) | -0.04 % |
Sundial Growers Inc.
|
SNDL | 1.06 (14.06.2021) | 0.95 % |
Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 11.05 (14.06.2021) | -0.54 % |
Thermo Fisher Scientific Inc.
|
TMO | 470.07 (14.06.2021) | 1.06 % |
Tilray, Inc.
|
TLRY | 19.16 (14.06.2021) | -3.67 % |
UnitedHealth Group, Inc.
|
UNH | 399.16 (14.06.2021) | 0.32 % |
Veeva Systems Inc.
|
VEEV | 303.9 (14.06.2021) | 1.57 % |
Zomedica Corp.
|
ZOM | 0.9458 (14.06.2021) | -0.08 % |
Zynerba Pharmaceuticals, Inc.
|
ZYNE | 5.66 (14.06.2021) | 0.35 % |
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.